ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 072

Musculoskeletal Ultrasound Findings in Children with Psoriasis

Laura Nedorezov, Tracy Ting and Patricia Vega-Fernandez, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Pediatric rheumatology, Psoriatic arthritis, Ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, March 30, 2023

Title: Posters: Clinical and Therapeutic I

Session Type: Poster Session A

Session Time: 6:00PM-7:00PM

Background/Purpose: The presentation of juvenile psoriatic arthritis (JPsA) in children with psoriasis can be insidious and poses a diagnostic challenge. Musculoskeletal ultrasound (MSUS) has emerged in recent years as a sensitive and non-invasive imaging modality to detect joint inflammation. A growing number of evidence has shown that adult psoriasis patients without signs of arthritis have findings of subclinical joint pathology on MSUS. These patients with identified imaging abnormalities are more likely to develop active psoriatic arthritis as demonstrated in longitudinal studies. No such research has been performed among children with psoriasis however, highlighting a critical gap in the understanding of pediatric psoriatic disease. The objective of this investigation is to describe MSUS and nail ultrasound (US) findings in children with psoriasis.

Methods: Grey-scale (B) mode and power Doppler (PD) mode US were utilized in this cross-sectional study to evaluate joint, enthesis, and nail findings in pediatric psoriasis patients (< 18 years old) without clinical symptoms of arthritis. Exclusion criteria included acute joint injury, trauma, or joint surgery within the last 3 months, on systemic treatment or oral corticosteroids in the last 2 months, or pregnancy. Each subject underwent a full musculoskeletal exam and MSUS evaluation of seven sites bilaterally: a) joints/nails – fingernails, MCP, and IP joints of the second and third fingers, as well as any finger with psoriatic nail involvement, patella, tibiotalar and subtalar joints, b) entheses – quadriceps, proximal and distal patellar tendon, Achilles, and plantar fascia calcaneal insertion. US images were assessed using an established pediatric-specific scoring system for the joints and semi-quantitative scoring approach for the nails. Enthesitis was evaluated according to the OMERACT definition. Demographic, clinical, and laboratory information was collected when available.

Results: Eleven patients were included until now. Demographic and clinical characteristics are shown in Table 1. The mean duration of the MSUS exam was 66 minutes. US characteristics of the nails studied are displayed in Table 2, and findings of the joints and entheses are shown in Table 3. 51 nails (83.6%) had abnormal nail plate structure per the Wortsman classification, and roughly 20% of nails had increased PD activity in either the nail bed or nail matrix classified as grade 2 or 3. Eight out of 11 patients (72.7%) had at least one grade 2 finding of synovitis on B-mode, with the PIP/DIP, suprapatellar, and anterior subtalar joint recesses most frequently affected. Two patients (18.2%) had enthesopathy involving the lower extremities identified on PD examination.

Conclusion: Subclinical inflammatory abnormalities of the nails, joints, and entheses were identified utilizing MSUS in children with psoriasis who did not have clinical manifestations of arthritis on exam. Ongoing studies involving additional pediatric psoriasis patients and healthy controls is underway to more clearly elucidate the significance of these findings.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: L. Nedorezov: None; T. Ting: None; P. Vega-Fernandez: None.

To cite this abstract in AMA style:

Nedorezov L, Ting T, Vega-Fernandez P. Musculoskeletal Ultrasound Findings in Children with Psoriasis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/musculoskeletal-ultrasound-findings-in-children-with-psoriasis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-ultrasound-findings-in-children-with-psoriasis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology